现代背景下主动脉内移植物部分与完全取出术
该研究回顾性分析了2001至2020年间单中心52例主动脉内移植物取出术,其中部分取出占61.5%。部分取出者失血量更多、急性肾损伤更频繁、ICU住院更长,但短期死亡率和长期生存率与完全取出相当。
要点
- 多数取出为外院置入的非索引性移植物(57.7%),最常见原因为瘤颈退变或瘤囊扩张(78.8%)。
- 部分取出较完全取出失血量更多、急性肾损伤更频繁、ICU住院更长。
- 部分与完全取出的30天死亡率和长期生存率无显著差异。
核心结论
- 本机构主动脉内移植物取出术随时间增加,部分取出占半数以上,由术者决定,失血量更多、急性肾损伤更频繁、ICU住院更长,但短期死亡率和长期生存率相当。
研究设计与样本
- 单中心回顾性分析,纳入2001至2020年在该城市四级中心取出的所有主动脉内移植物,排除1例感染性内移植物,共52例符合标准。
主要发现
- 52例中57.7%为非索引性取出(外院置入),男性占86.5%,中位年龄74岁(IQR 70-78岁),61.5%在研究第二个十年完成。
- 最常见取出移植物为Gore Excluder(9例)、Cook Zenith(8例)、Endologix AFX(7例)、Medtronic Endurant(5例)和Medtronic Talent(5例)。
- 78.8%因瘤颈退变或瘤囊扩张取出,5例因初始密封失败、5例因症状性扩张、7例因破裂取出。
- 中位移植物留置时间4.2年(IQR 2.6-5.1年),索引与非索引取出相似(4.2年 vs 4.1年);部分取出者留置时间3.2年 vs 完全取出4.4年。
- 部分取出占61.5%,在索引取出中更常见(68.2% vs 56.7%);中位住院8天,中位ICU住院3天,非索引取出(4天 vs 3天)和部分取出(4天 vs 3天)无显著差异。
临床怎么用
- 作者指出部分取出由术者根据患者危险因素、动脉瘤表现(无症状、症状性或破裂)及解剖或术中因素(包括内漏类型)决定,无预设方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite the progressive advancement of devices for endovascular aortic repair (EVAR), endografts continue to fail, requiring explant. We present a single-institutional experience of EVAR explants, characterizing modern failure modes, presentation, and outcomes for partial and complete EVAR explantation. METHODS: A retrospective analysis was performed of all EVARs explanted at an urban quaternary center from 2001 to 2020, with one infected endograft excluded. Patient and graft characteristics, indications, and perioperative and long-term outcomes were analyzed. Partial versus complete explants were performed per surgeon discretion without a predefined protocol. This process was informed by patient risk factors; asymptomatic, symptomatic, or ruptured aneurysm presentation; and anatomical or intraoperative factors, including endoleak type. RESULTS: From 2001 to 2020, 52 explants met the inclusion and exclusion criteria. More than one-half (57.7%) were explants of EVAR devices placed at outside institutions, designated nonindex explants. Most patients were male (86.5%), the median age was 74 years (interquartile range, 70-78 years). More than one-half (61.5%) were performed in the second decade of the study period. The most commonly explanted grafts were Gore Excluder (n = 9 grafts), Cook Zenith (n = 8), Endologix AFX (n = 7), Medtronic Endurant (n = 5), and Medtronic Talent (n = 5). Most grafts (78.8%) were explanted for neck degeneration or sac expansion. Five were explanted for initial seal failure, five for symptomatic expansion, and seven for rupture. The median implant duration was 4.2 years, although ranging widely (interquartile range, 2.6-5.1 years), but similar between index and nonindex explants (4.2 years vs 4.1 years). Partial explantation was performed in 61.5%, with implant duration slightly lower, 3.2 years versus 4.4 years for complete explants. Partial explantation was more frequent in index explants (68.2% vs 56.7%). The median length of stay was 8 days. The median intensive care unit length of stay was 3 days, without significant differences in nonindex explants (4 days vs 3 days) and partial explants (4 days vs 3 days). Thirty-day mortality occurred in two nonindex explants (one partial and one complete explant). Thirty-day readmission was similar between partial and complete explants (9.7% vs 5.0%), without accounting for nonindex readmissions. Long-term survival was comparable between partial and complete explants in Cox regression (hazard ratio, 2.45; 95% confidence interval, 0.79-7.56; P = .12). CONCLUSIONS: Explants of EVAR devices have increased over time at our institution. Partial explant was performed in more than one-half of cases, per operating surgeon discretion, demonstrating higher blood loss, more frequent acute kidney injury, and longer intensive care unit stays, however with comparable short-term mortality and long-term survival.
引用
- Feldman ZM, Kim D, Roddy C, et al. Partial and complete explantation of aortic endografts in the modern era. J Vasc Surg. 2022. PMID: 35868421. doi:10.1016/j.jvs.2022.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。